ID   PYDC1_HUMAN             Reviewed;          89 AA.
AC   Q8WXC3; B2R8L4; Q8NFP8;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   07-APR-2021, entry version 133.
DE   RecName: Full=Pyrin domain-containing protein 1 {ECO:0000305};
DE   AltName: Full=PAAD-only protein 1 {ECO:0000303|PubMed:12656673};
DE   AltName: Full=Pyrin-only protein 1 {ECO:0000303|PubMed:12656673};
DE   AltName: Full=cellular POP1 {ECO:0000303|PubMed:17178784};
DE            Short=cPOP1 {ECO:0000303|PubMed:17178784};
GN   Name=PYDC1 {ECO:0000312|HGNC:HGNC:30261};
GN   Synonyms=ASC2 {ECO:0000303|PubMed:12656673}, ASCI,
GN   POP1 {ECO:0000303|PubMed:12656673}, PYC1 {ECO:0000312|EMBL:AAN03745.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11786556; DOI=10.1074/jbc.m112208200;
RA   Manji G.A., Wang L., Geddes B.J., Brown M., Merriam S., Al-Garawi A.,
RA   Mak S., Lora J.M., Briskin M., Jurman M., Cao J., DiStefano P.S.,
RA   Bertin J.;
RT   "PYPAF1: a PYRIN-containing APAF1-like protein that assembles with ASC and
RT   activates NF-kB.";
RL   J. Biol. Chem. 277:11570-11575(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, PHOSPHORYLATION, AND INTERACTION WITH PYCARD/ASC.
RC   TISSUE=Heart;
RX   PubMed=12656673; DOI=10.1042/bj20030304;
RA   Stehlik C., Krajewska M., Welsh K., Krajewski S., Godzik A., Reed J.C.;
RT   "The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated
RT   nuclear-factor-kappa B and pro-caspase-1 regulation.";
RL   Biochem. J. 373:101-113(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Martinon F., Hofmann K., Tschopp J.;
RT   "Pyc1 a novel regulator of the inflammosome.";
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH PYCARD, AND SUBCELLULAR LOCATION.
RX   PubMed=17178784; DOI=10.1128/iai.01315-06;
RA   Dorfleutner A., Bryan N.B., Talbott S.J., Funya K.N., Rellick S.L.,
RA   Reed J.C., Shi X., Rojanasakul Y., Flynn D.C., Stehlik C.;
RT   "Cellular pyrin domain-only protein 2 is a candidate regulator of
RT   inflammasome activation.";
RL   Infect. Immun. 75:1484-1492(2007).
RN   [8]
RP   FUNCTION.
RX   PubMed=24871464; DOI=10.1038/gene.2014.30;
RA   Porter K.A., Duffy E.B., Nyland P., Atianand M.K., Sharifi H., Harton J.A.;
RT   "The CLRX.1/NOD24 (NLRP2P) pseudogene codes a functional negative regulator
RT   of NF-kappaB, pyrin-only protein 4.";
RL   Genes Immun. 15:392-403(2014).
RN   [9]
RP   STRUCTURE BY NMR.
RX   PubMed=16905547; DOI=10.1074/jbc.m605458200;
RA   Natarajan A., Ghose R., Hill J.M.;
RT   "Structure and dynamics of ASC2, a pyrin domain-only protein that regulates
RT   inflammatory signaling.";
RL   J. Biol. Chem. 281:31863-31875(2006).
CC   -!- FUNCTION: Associates with PYCARD/ASC and modulates its ability to
CC       collaborate with MEFV/pyrin and NLRP3/cryopyrin in NF-kappa-B and pro-
CC       caspase-1 activation. Suppresses kinase activity of NF-kappa-B
CC       inhibitor kinase (IKK) complex, expression of NF-kappa-B inducible
CC       genes and inhibits NF-kappa-B activation by cytokines and LPS.
CC       {ECO:0000269|PubMed:12656673, ECO:0000269|PubMed:24871464}.
CC   -!- SUBUNIT: Interacts with PYCARD/ASC (via pyrin domain).
CC       {ECO:0000269|PubMed:12656673, ECO:0000269|PubMed:17178784}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12656673}.
CC       Note=Recruited to specks formed by PYCARD within the cytoplasm.
CC       {ECO:0000269|PubMed:17178784}.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in monocytes, macrophages
CC       and granulocytes. {ECO:0000269|PubMed:12656673}.
CC   -!- PTM: Phosphorylated. {ECO:0000269|PubMed:12656673}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF454669; AAL58439.1; -; mRNA.
DR   EMBL; AY163727; AAO23114.1; -; mRNA.
DR   EMBL; AF467809; AAN03745.1; -; mRNA.
DR   EMBL; AK313418; BAG36211.1; -; mRNA.
DR   EMBL; CH471192; EAW52147.1; -; Genomic_DNA.
DR   EMBL; BC105033; AAI05034.1; -; mRNA.
DR   EMBL; BC105035; AAI05036.1; -; mRNA.
DR   CCDS; CCDS10710.1; -.
DR   RefSeq; NP_690865.1; NM_152901.3.
DR   PDB; 2HM2; NMR; -; Q=1-89.
DR   PDB; 4QOB; X-ray; 2.70 A; A/B=1-89.
DR   PDBsum; 2HM2; -.
DR   PDBsum; 4QOB; -.
DR   SMR; Q8WXC3; -.
DR   BioGRID; 129281; 1.
DR   IntAct; Q8WXC3; 1.
DR   STRING; 9606.ENSP00000304336; -.
DR   BioMuta; PYDC1; -.
DR   DMDM; 74730989; -.
DR   EPD; Q8WXC3; -.
DR   MassIVE; Q8WXC3; -.
DR   PaxDb; Q8WXC3; -.
DR   PeptideAtlas; Q8WXC3; -.
DR   PRIDE; Q8WXC3; -.
DR   ProteomicsDB; 75005; -.
DR   Antibodypedia; 27781; 153 antibodies.
DR   Ensembl; ENST00000302964; ENSP00000304336; ENSG00000169900.
DR   GeneID; 260434; -.
DR   KEGG; hsa:260434; -.
DR   UCSC; uc002ebo.4; human.
DR   CTD; 260434; -.
DR   DisGeNET; 260434; -.
DR   GeneCards; PYDC1; -.
DR   HGNC; HGNC:30261; PYDC1.
DR   HPA; ENSG00000169900; Tissue enhanced (brain, skin).
DR   MIM; 615700; gene.
DR   neXtProt; NX_Q8WXC3; -.
DR   OpenTargets; ENSG00000169900; -.
DR   PharmGKB; PA142671111; -.
DR   VEuPathDB; HostDB:ENSG00000169900.7; -.
DR   eggNOG; KOG2177; Eukaryota.
DR   GeneTree; ENSGT00940000164730; -.
DR   HOGENOM; CLU_163053_0_0_1; -.
DR   InParanoid; Q8WXC3; -.
DR   OMA; QLVASYY; -.
DR   OrthoDB; 574602at2759; -.
DR   PhylomeDB; Q8WXC3; -.
DR   PathwayCommons; Q8WXC3; -.
DR   BioGRID-ORCS; 260434; 8 hits in 989 CRISPR screens.
DR   EvolutionaryTrace; Q8WXC3; -.
DR   GenomeRNAi; 260434; -.
DR   Pharos; Q8WXC3; Tbio.
DR   PRO; PR:Q8WXC3; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q8WXC3; protein.
DR   Bgee; ENSG00000169900; Expressed in cerebellum and 81 other tissues.
DR   Genevisible; Q8WXC3; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HGNC-UCL.
DR   GO; GO:0008385; C:IkappaB kinase complex; IDA:HGNC-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:HGNC-UCL.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0045087; P:innate immune response; IDA:HGNC-UCL.
DR   GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IDA:HGNC-UCL.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IDA:HGNC-UCL.
DR   GO; GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0032731; P:positive regulation of interleukin-1 beta production; IDA:HGNC-UCL.
DR   GO; GO:0033209; P:tumor necrosis factor-mediated signaling pathway; IDA:HGNC-UCL.
DR   InterPro; IPR004020; DAPIN.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   InterPro; IPR002398; Pept_C14.
DR   PANTHER; PTHR10454; PTHR10454; 1.
DR   Pfam; PF02758; PYRIN; 1.
DR   SMART; SM01289; PYRIN; 1.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   PROSITE; PS50824; DAPIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Phosphoprotein; Reference proteome;
KW   Signal transduction inhibitor.
FT   CHAIN           1..89
FT                   /note="Pyrin domain-containing protein 1"
FT                   /id="PRO_0000280593"
FT   DOMAIN          1..89
FT                   /note="Pyrin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00061"
FT   CONFLICT        37
FT                   /note="E -> G (in Ref. 3; AAN03745)"
FT                   /evidence="ECO:0000305"
FT   HELIX           4..13
FT                   /evidence="ECO:0007744|PDB:4QOB"
FT   HELIX           17..27
FT                   /evidence="ECO:0007744|PDB:4QOB"
FT   HELIX           41..45
FT                   /evidence="ECO:0007744|PDB:4QOB"
FT   HELIX           49..60
FT                   /evidence="ECO:0007744|PDB:4QOB"
FT   HELIX           62..75
FT                   /evidence="ECO:0007744|PDB:4QOB"
FT   HELIX           79..88
FT                   /evidence="ECO:0007744|PDB:4QOB"
SQ   SEQUENCE   89 AA;  10107 MW;  4CDF6D672DDDD98E CRC64;
     MGTKREAILK VLENLTPEEL KKFKMKLGTV PLREGFERIP RGALGQLDIV DLTDKLVASY
     YEDYAAELVV AVLRDMRMLE EAARLQRAA
//
